{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:08:32Z","timestamp":1794330512379,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canlet.2024.216798","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T04:38:19Z","timestamp":1710131899000},"page":"216798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer"],"prefix":"10.1016","volume":"588","author":[{"given":"Yang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanhuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2380-3717","authenticated-orcid":false,"given":"Kefeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2024.216798_bib1","first-page":"209","article-title":"Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canlet.2024.216798_bib2","first-page":"1","article-title":"Treatment of patients with early-stage colorectal cancer: ASCO Resource-Stratified guideline","volume":"5","author":"Costas-Chavarri","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.canlet.2024.216798_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2021.01.009","article-title":"Long non-coding RNAs in colorectal cancer: novel oncogenic mechanisms and promising clinical applications","volume":"504","author":"Yang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216798_bib4","doi-asserted-by":"crossref","first-page":"n1855","DOI":"10.1136\/bmj.n1855","article-title":"Screening and prevention of colorectal cancer","volume":"374","author":"Kanth","year":"2021","journal-title":"BMJ"},{"issue":"10304","key":"10.1016\/j.canlet.2024.216798_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.canlet.2024.216798_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S1470-2045(20)30482-4","article-title":"Pembrolizumab plus axitinib: another step ahead in advanced renal cell carcinoma","volume":"21","author":"Procopio","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10308","key":"10.1016\/j.canlet.2024.216798_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrclinonc.2013.208","article-title":"Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer","volume":"11","author":"Drake","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-14-0098","article-title":"Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNgamma-dependent cell-cycle arrest","volume":"3","author":"Matsushita","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.216798_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216798_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606489","article-title":"The role of structure in the biology of interferon signaling","volume":"11","author":"Walter","year":"2020","journal-title":"Front. Immunol."},{"issue":"6 Suppl","key":"10.1016\/j.canlet.2024.216798_bib13","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1111\/1523-1747.ep12874776","article-title":"Biologic effects of interferons","volume":"95","author":"Gresser","year":"1990","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.canlet.2024.216798_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-13-0985","article-title":"T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy","volume":"4","author":"Melero","year":"2014","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.canlet.2024.216798_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-gamma: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216798_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"Ido in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2024.216798_bib17","first-page":"2128","article-title":"Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human\/mouse T84.66 genes in myeloma and Chinese hamster ovary cells","volume":"50","author":"Neumaier","year":"1990","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2024.216798_bib18","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/2326-6066.CIR-19-0228","article-title":"Trifluridine\/tipiracil plus oxaliplatin improves PD-1 blockade in colorectal cancer by inducing immunogenic cell death and depleting macrophages","volume":"7","author":"Limagne","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.216798_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1023668705040","article-title":"Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis","volume":"8","author":"Chawla-Sarkar","year":"2003","journal-title":"Apoptosis"},{"issue":"33","key":"10.1016\/j.canlet.2024.216798_bib20","doi-asserted-by":"crossref","first-page":"E3109","DOI":"10.1073\/pnas.1301218110","article-title":"Interferon-induced RIP1\/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases","volume":"110","author":"Thapa","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.canlet.2024.216798_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205246","article-title":"Cancer-associated fibroblast functions as a road-block in cancer therapy","volume":"13","author":"De","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.canlet.2024.216798_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41419-020-03036-1","article-title":"Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C(+) CD8(+) T cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.canlet.2024.216798_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000490585","article-title":"Potential role of gr-1+ CD8+ T lymphocytes as a source of interferon-gamma and M1\/M2 polarization during the acute phase of murine Legionella pneumophila pneumonia","volume":"10","author":"Kusaka","year":"2018","journal-title":"J. Innate Immun."},{"issue":"11","key":"10.1016\/j.canlet.2024.216798_bib24","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1084\/jem.20062376","article-title":"Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation","volume":"204","author":"Xiao","year":"2007","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.canlet.2024.216798_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071030","article-title":"The immunogenicity of colorectal cancer in relation to tumor development and treatment","volume":"17","author":"de Vries","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.216798_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5184075","article-title":"Cancer immunotherapy and identification of prognostic and predictive biomarkers","volume":"2018","author":"Criscitiello","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"7","key":"10.1016\/j.canlet.2024.216798_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","article-title":"Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"West","year":"2019","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.canlet.2024.216798_bib28","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.19.03296","article-title":"Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase ib trial (REGONIVO, EPOC1603)","volume":"38","author":"Fukuoka","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2024.216798_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamaoncol.2020.0910","article-title":"Effect of combined immune checkpoint inhibition vs best supportive Care alone in patients with advanced colorectal cancer: the Canadian cancer trials group CO.26 study","volume":"6","author":"Chen","year":"2020","journal-title":"JAMA Oncol."},{"issue":"14","key":"10.1016\/j.canlet.2024.216798_bib30","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/MCB.05445-11","article-title":"NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis","volume":"31","author":"Thapa","year":"2011","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.canlet.2024.216798_bib31","first-page":"3399","article-title":"A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice","volume":"61","author":"Nakajima","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216798_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2024.216798_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1373231","article-title":"Toll-like receptor 2 ligand and interferon-gamma suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells","volume":"7","author":"Shime","year":"2017","journal-title":"OncoImmunology"},{"issue":"4","key":"10.1016\/j.canlet.2024.216798_bib35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/hep.23841","article-title":"Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver","volume":"52","author":"Cripps","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.canlet.2024.216798_bib36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/eji.200939903","article-title":"Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF","volume":"40","author":"Dolcetti","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib38","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.canlet.2024.216798_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1737369","article-title":"Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq","volume":"9","author":"Carmona","year":"2020","journal-title":"OncoImmunology"},{"issue":"12","key":"10.1016\/j.canlet.2024.216798_bib40","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2460\/ajvr.1985.46.12.2585","article-title":"Experimentally induced pneumonic pasteurellosis: dose-response relationships and protection against natural reinfection in calves","volume":"46","author":"Hilwig","year":"1985","journal-title":"Am. J. Vet. Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.216798_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imm.13233","article-title":"Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin-derived mutant epitopes","volume":"161","author":"Dominguez-Romero","year":"2020","journal-title":"Immunology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:44:24Z","timestamp":1760816664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":41,"alternative-id":["S0304383524001915"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216798","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216798"}}